| 0 |
LIVER IRON CONCENTRATION ABNORMAL |
1 |
0.0400 |
| 1 |
SUBMANDIBULAR ABSCESS |
1 |
0.0167 |
| 2 |
GRAFT VERSUS HOST DISEASE ORAL |
1 |
0.0156 |
| 3 |
RASH FOLLICULAR |
1 |
0.0065 |
| 4 |
CHEST TUBE INSERTION |
1 |
0.0053 |
| 5 |
CORNEAL INFECTION |
1 |
0.0046 |
| 6 |
GRAFT VERSUS HOST DISEASE IN EYE |
1 |
0.0043 |
| 7 |
GRAFT VERSUS HOST DISEASE IN LUNG |
2 |
0.0042 |
| 8 |
GASTROINTESTINAL HYPERMOTILITY |
1 |
0.0023 |
| 9 |
BLOOD CREATINE PHOSPHOKINASE ABNORMAL |
1 |
0.0022 |
| 10 |
BLAST CELLS PRESENT |
1 |
0.0021 |
| 11 |
GLARE |
1 |
0.0019 |
| 12 |
ALVEOLAR PROTEINOSIS |
1 |
0.0017 |
| 13 |
MONOCLONAL IMMUNOGLOBULIN PRESENT |
1 |
0.0013 |
| 14 |
VEIN COLLAPSE |
1 |
0.0013 |
| 15 |
CREATINE KINASE INCREASED |
1 |
0.0013 |
| 16 |
PSEUDOMONAS TEST POSITIVE |
1 |
0.0012 |
| 17 |
HYPERMETROPIA |
1 |
0.0011 |
| 18 |
GASTROINTESTINAL VIRAL INFECTION |
1 |
0.0010 |
| 19 |
BLOOD FIBRINOGEN DECREASED |
1 |
0.0009 |
| 20 |
CHRONIC GRAFT VERSUS HOST DISEASE |
3 |
0.0008 |
| 21 |
INTERCEPTED PRODUCT SELECTION ERROR |
1 |
0.0008 |
| 22 |
SYMPTOM RECURRENCE |
4 |
0.0007 |
| 23 |
ACUTE LEUKAEMIA |
1 |
0.0006 |
| 24 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
2 |
0.0006 |
| 25 |
GRAFT VERSUS HOST DISEASE |
4 |
0.0006 |
| 26 |
BLOOD IRON INCREASED |
1 |
0.0005 |
| 27 |
SKIN INDURATION |
1 |
0.0005 |
| 28 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
1 |
0.0005 |
| 29 |
MYOPIA |
1 |
0.0004 |
| 30 |
LIPASE INCREASED |
3 |
0.0004 |
| 31 |
PROTEIN TOTAL INCREASED |
1 |
0.0004 |
| 32 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0004 |
| 33 |
LIVER FUNCTION TEST INCREASED |
7 |
0.0003 |
| 34 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 35 |
BK VIRUS INFECTION |
1 |
0.0003 |
| 36 |
HYPERTRANSAMINASAEMIA |
2 |
0.0003 |
| 37 |
AMYLASE INCREASED |
1 |
0.0003 |
| 38 |
BLEPHARITIS |
1 |
0.0002 |
| 39 |
CYSTITIS HAEMORRHAGIC |
1 |
0.0002 |
| 40 |
ANAPHYLACTOID REACTION |
1 |
0.0002 |
| 41 |
PULSELESS ELECTRICAL ACTIVITY |
1 |
0.0002 |
| 42 |
CARDIAC TAMPONADE |
1 |
0.0002 |
| 43 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
| 44 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 45 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
1 |
0.0002 |
| 46 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 47 |
ASPERGILLUS INFECTION |
1 |
0.0002 |
| 48 |
PULMONARY MASS |
2 |
0.0001 |
| 49 |
INSURANCE ISSUE |
2 |
0.0001 |
| 50 |
MUSCLE STRAIN |
1 |
0.0001 |
| 51 |
INFUSION RELATED REACTION |
7 |
0.0001 |
| 52 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
3 |
0.0001 |
| 53 |
ATELECTASIS |
1 |
0.0001 |
| 54 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
3 |
0.0001 |
| 55 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 56 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 57 |
BLOOD GLUCOSE FLUCTUATION |
1 |
0.0001 |
| 58 |
INTERCEPTED PRODUCT PREPARATION ERROR |
1 |
0.0001 |
| 59 |
TACHYPNOEA |
1 |
0.0001 |
| 60 |
ANAPHYLACTIC REACTION |
4 |
0.0001 |
| 61 |
BRONCHOSPASM |
1 |
0.0001 |
| 62 |
MYELODYSPLASTIC SYNDROME |
1 |
0.0001 |
| 63 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 64 |
DISEASE RECURRENCE |
3 |
0.0001 |
| 65 |
CANDIDA INFECTION |
1 |
0.0001 |
| 66 |
PANCREATITIS |
3 |
0.0001 |
| 67 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 68 |
ASPARTATE AMINOTRANSFERASE INCREASED |
3 |
0.0001 |
| 69 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 70 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 71 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 72 |
ALANINE AMINOTRANSFERASE INCREASED |
3 |
0.0000 |
| 73 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 74 |
EATING DISORDER |
1 |
0.0000 |
| 75 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 76 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 77 |
OFF LABEL USE |
38 |
0.0000 |
| 78 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
3 |
0.0000 |
| 79 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 80 |
PRESYNCOPE |
1 |
0.0000 |
| 81 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 82 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 83 |
CATARACT |
2 |
0.0000 |
| 84 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
6 |
0.0000 |
| 85 |
HEPATIC FAILURE |
1 |
0.0000 |
| 86 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 87 |
DELIRIUM |
1 |
0.0000 |
| 88 |
RASH MACULAR |
1 |
0.0000 |
| 89 |
HYPOXIA |
1 |
0.0000 |
| 90 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 91 |
PANIC ATTACK |
1 |
0.0000 |
| 92 |
RESTLESSNESS |
1 |
0.0000 |
| 93 |
PRODUCT DOSE OMISSION ISSUE |
8 |
0.0000 |
| 94 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 95 |
TACHYCARDIA |
2 |
0.0000 |
| 96 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 97 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 98 |
INFECTION |
3 |
0.0000 |
| 99 |
DRY EYE |
1 |
0.0000 |
| 100 |
CELLULITIS |
1 |
0.0000 |
| 101 |
ILLNESS |
2 |
0.0000 |
| 102 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 103 |
OEDEMA |
1 |
0.0000 |
| 104 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 105 |
URTICARIA |
3 |
0.0000 |
| 106 |
DYSPHONIA |
1 |
0.0000 |
| 107 |
STOMATITIS |
1 |
0.0000 |
| 108 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 109 |
CONDITION AGGRAVATED |
5 |
0.0000 |
| 110 |
PRODUCT USE IN UNAPPROVED INDICATION |
4 |
0.0000 |
| 111 |
VISION BLURRED |
2 |
0.0000 |
| 112 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 113 |
AGITATION |
1 |
0.0000 |
| 114 |
BRONCHITIS |
1 |
0.0000 |
| 115 |
DYSGEUSIA |
1 |
0.0000 |
| 116 |
WEIGHT INCREASED |
3 |
0.0000 |
| 117 |
CARDIAC FAILURE |
1 |
0.0000 |
| 118 |
THROMBOSIS |
1 |
0.0000 |
| 119 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 120 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 121 |
DYSPNOEA |
6 |
0.0000 |
| 122 |
PRURITUS |
4 |
0.0000 |
| 123 |
ALOPECIA |
2 |
0.0000 |
| 124 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 125 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 126 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 127 |
HAEMORRHAGE |
1 |
0.0000 |
| 128 |
PNEUMONIA |
3 |
0.0000 |
| 129 |
INFLUENZA |
1 |
0.0000 |
| 130 |
SEPSIS |
1 |
0.0000 |
| 131 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 132 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 133 |
BACK PAIN |
2 |
0.0000 |
| 134 |
CHILLS |
1 |
0.0000 |
| 135 |
VOMITING |
4 |
0.0000 |
| 136 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 137 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 138 |
DIARRHOEA |
5 |
0.0000 |
| 139 |
FATIGUE |
6 |
0.0000 |
| 140 |
NAUSEA |
6 |
0.0000 |
| 141 |
WEIGHT DECREASED |
2 |
0.0000 |
| 142 |
DEATH |
6 |
0.0000 |
| 143 |
HYPOAESTHESIA |
1 |
0.0000 |
| 144 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 145 |
HOSPITALISATION |
1 |
0.0000 |
| 146 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 147 |
PARAESTHESIA |
1 |
0.0000 |
| 148 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 149 |
MYALGIA |
1 |
0.0000 |
| 150 |
CHEST PAIN |
1 |
0.0000 |
| 151 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 152 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 153 |
ANAEMIA |
1 |
0.0000 |
| 154 |
HEADACHE |
3 |
0.0000 |
| 155 |
RASH |
2 |
0.0000 |
| 156 |
CONSTIPATION |
1 |
0.0000 |
| 157 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 158 |
DECREASED APPETITE |
1 |
0.0000 |
| 159 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 160 |
FEELING ABNORMAL |
1 |
0.0000 |
| 161 |
ANXIETY |
1 |
0.0000 |
| 162 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 163 |
PAIN |
2 |
0.0000 |
| 164 |
PYREXIA |
1 |
0.0000 |
| 165 |
ASTHENIA |
1 |
0.0000 |
| 166 |
ARTHRALGIA |
1 |
0.0000 |
| 167 |
DRUG INEFFECTIVE |
3 |
0.0000 |